Phase II Trial for Large ER-Negative Breast Cancers
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Malignant Neoplasm of Female Breast
Interventions: DRUG: Epirubicin|DRUG: Cyclophosphamide|DRUG: Docetaxel|DRUG: Capecitabine|RADIATION: Radiation Therapy
Sponsor: University of Colorado, Denver